Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites.

Source:http://linkedlifedata.com/resource/pubmed/id/17376008

Download in:

View as

General Info

PMID
17376008